Toggle navigation
Menu
About Us
Investment Strategy
Team
Portfolio
News
Contact Us
Limited Partners
News
ABIOMED Impella Therapy Receives FDA Approval for Cardiogenic Shock After Heart Attack/Heart Surgery
Apr 07 2016
Recent News
VitalConnect Secures over $30 Million in Oversubscribed Series F Financing
Grundium Oy Announces the Appointment of Head of the US Business and Two Independent Board Members
EW Healthcare Partners Announces Platform Investment in Enercon Technologies
Frost & Sullivan Recognizes VitalConnect with the 2022 New Product Innovation Award for Its Leading-edge Wearable Patient Monitoring Device
BioTissue Completes Name Change
Related: Team
Marty Sutter
Related: Portfolio
